Cytek Biosciences, Inc. (CTKB)
NASDAQ: CTKB · Real-Time Price · USD
5.60
-0.22 (-3.78%)
At close: Nov 26, 2025, 4:00 PM EST
5.53
-0.07 (-1.25%)
After-hours: Nov 26, 2025, 6:45 PM EST
Cytek Biosciences Market Cap
Cytek Biosciences has a market cap or net worth of $716.04 million as of November 26, 2025. Its market cap has decreased by -21.15% in one year.
Market Cap
716.04M
Enterprise Value
479.14M
1-Year Change
-21.15%
Ranking
Category
Stock Price
$5.60
Market Cap Chart
Since the IPO on July 23, 2021, Cytek Biosciences's market cap has decreased from $2.26B to $716.04M, a decrease of -68.33%. That is a compound annual growth rate of -23.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 25, 2025 | 744.17M | -10.98% |
| Dec 31, 2024 | 835.98M | -32.38% |
| Dec 29, 2023 | 1.24B | -10.21% |
| Dec 30, 2022 | 1.38B | -36.91% |
| Dec 31, 2021 | 2.18B | -3.47% |
| Jul 23, 2021 | 2.26B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 958.20B |
| Johnson & Johnson | 496.44B |
| AbbVie | 405.63B |
| UnitedHealth Group | 289.01B |
| AstraZeneca | 283.06B |
| Merck & Co. | 249.20B |
| Novartis AG | 244.50B |
| Abbott Laboratories | 221.17B |